Page last updated: 2024-09-03

celastrol and Chemical and Drug Induced Liver Injury, Chronic

celastrol has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Dai, M; Li, F; Rao, Q; Wu, ZE; Zhang, T; Zhao, Q1
Chen, X; Cheng, W; Ding, X; Liu, X; Wan, Y; Wu, L; Yang, B; Yang, N; Yu, S; Yu, X; Zhang, G; Zheng, J1

Other Studies

2 other study(ies) available for celastrol and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Tripterygium wilfordii protects against an animal model of autoimmune hepatitis.
    Journal of ethnopharmacology, 2023, Jun-12, Volume: 309

    Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Concanavalin A; Hepatitis, Autoimmune; Mice; Models, Animal; Pentacyclic Triterpenes; Tripterygium; Triterpenes

2023
Celastrol-loaded biomimetic nanodrug ameliorates APAP-induced liver injury through modulating macrophage polarization.
    Journal of molecular medicine (Berlin, Germany), 2023, Volume: 101, Issue:6

    Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Biomimetics; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Humans; Liver; Liver Diseases; Macrophages; Mice; Mice, Inbred C57BL; Nanoparticles

2023